Ruth M. Rothstein CORE Center

Last updated

The Ruth M. Rothstein CORE Center is a medical facility in the Illinois Medical District, located at 2020 West Harrison Street in Chicago. It was founded by the Cook County Bureau of Health Services, and cares for people with diseases such as HIV/AIDS. In its mission statement, it explains its goals as:

Contents

to provide the highest quality care for persons and families affected by infectious diseases, with respect, dignity and compassion, without regard to the ability to pay; to ensure a patient-centered and consumer-guided environment; and to seek to better understand and to prevent these diseases through education and research.

Design and Language Access

The center was designed with the involvement of "clients and providers". Its design could be seen as futuristic, with glass and white walls throughout.

To address language access needs of diverse-linguistic populations, the center designated a Bilingual Clinic staffed with Spanish-speaking physicians and medical staff for Spanish-speaking consumers. An in-house Spanish language interpreter is staffed to assist limited English proficient consumers at the facility. Interpreter services through telephonic and video remote interpreting are available for the deaf or hard of hearing, and spoken languages of lesser diffusion.

Education

As well as carrying out its duties to the community, the center provides medical tutoring about HIV/AIDS to local medics. The center has also made attempts to educate the community about the nature of such diseases, with education resources readily available at the site.

Care

The center focuses on social care, primary care and special care:

Social Care

This involves subjects such as support groups and counselling programs. Legal assistance is also provided.

Primary Care

Primary Care at the CORE Center involves screening for sexually transmitted diseases (STDs) and care units for HIV.

Special Care

A wide range of special care is provided:

Research

Clinical studies

The CORE center performs some clinical studies into HIV/AIDS. These are first approved by the Research Committee and the Scientific Committee/Institutional Review Board. The studies are also observed by the Food and Drug Administration. Participants are then required to sign a consent form informing them of any possible danger. All studies are closely monitored by qualified nurses. Not everyone can participate: requirements have to be met so that the staff feel that it is safe to carry out the study.

Survey and Observational

Surveys and observational studies are carried out to investigate the effects of diseases. As with the clinical studies, the participants must first meet requirements set by the center.

Notes

    Coordinates: 41°52′28.2″N87°40′37.7″W / 41.874500°N 87.677139°W / 41.874500; -87.677139

    Related Research Articles

    The National Institute of Allergy and Infectious Diseases (NIAID) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

    The National Microbiology Laboratory (NML) is part of the Infectious Disease Prevention and Control Branch of the Public Health Agency of Canada (PHAC), the agency of the Government of Canada that is responsible for public health, health emergency preparedness and response, and infectious and chronic disease control and prevention.

    AIDS Clinical Trials Group

    The AIDS Clinical Trials Group network (ACTG) is one of the largest HIV clinical trials organizations in the world, playing a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV and AIDS in the United States and the developing world. The ACTG is composed of, and directed by, leading clinical scientists in HIV/AIDS therapeutic research. The ACTG is funded by the Department of Health and Human Services, National Institutes of Health through the National Institute of Allergy and Infectious Diseases.

    The Women's Interagency HIV Study (WIHS) was established in August 1993 to investigate the impact and progression of HIV disease in women. The WIHS enrolls both HIV-positive and HIV-negative women. The core portion of the study includes a detailed and structured interview, physical and gynecologic examination, and laboratory testing. The WIHS participants are also asked to enroll in various sub-studies, such as cardiovascular, metabolic, musculoskeletal, and neurocognition. New proposals for WIHS sub-studies are submitted for approval by various scientific investigators from around the world.

    Merle Sande(September 2, 1939 – November 4, 2007) was a leading American infectious-diseases expert whose early recognition of the looming public health crisis posed by AIDS led to the development of basic protocols for how to handle infected patients. He graduated from Washington State University and received his MD degree from the University of Washington, School of Medicine in Seattle.

    Robert R. Redfield American medical researcher

    Robert Ray Redfield Jr. is an American virologist. He is the current Director of the Centers for Disease Control and Prevention, and the current Administrator of the Agency for Toxic Substances and Disease Registry, having served in both positions since March 2018.

    HIV Clinical Resource is a health information service in New York State, which provides clinical information and guidance on HIV for the use of healthcare providers and patients.

    Health in Ghana

    In precolonial Ghana, infectious diseases were the main cause of morbidity and mortality.

    Michael S. Saag is a physician and prominent HIV/AIDS researcher at the University of Alabama at Birmingham (UAB). He holds the Jim Straley Chair in AIDS Research, is Director of the Division of Infectious Disease and of the William C. Gorgas Center for Geographic Medicine, and Director of the Center for AIDS Research. He is also the founder of the 1917 Clinic, a comprehensive AIDS treatment and research center at UAB Saag is a frequent lecturer at AIDS conferences around the world and is credited with performing pioneering clinical trials for several antiretroviral drugs now in common use for HIV treatment and for first demonstrating the clinical value of "viral-load testing" in HIV/AIDS treatment. In 2009 Saag was elected chairman of the HIV Medicine Association of the Infectious Diseases Society of America. In 2019 Saag began serving on the Presidential Advisory Council on HIV/AIDS.

    The United States Military HIV Research Program was initiated by the United States Congress in 1986, in reaction to the threat of lost effectiveness of U.S./Allied troops due to HIV infection. The mission of MHRP is to develop an HIV-1 vaccine, provide prevention, care, and treatment, and conduct meaningful HIV/AIDS research for the global community through the President's Emergency Plan for AIDS Relief (PEPFAR). It is centered at the Walter Reed Army Institute of Research (WRAIR), and has established five international research sites in Africa and Asia. MHRP also partners with the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. MHRP works closely with The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), most notably in the development of the RV144 HIV vaccine in Thailand. MHRP is the largest research program supported by the HJF.

    University of Florida College of Medicine-Jacksonville

    The University of Florida College of Medicine – Jacksonville is the largest of the three University of Florida Health Science Center Jacksonville colleges — medicine, nursing and pharmacy. The college's 16 clinical science departments house more than 380 faculty members and 300 residents and fellows. The college offers 34 accredited graduate medical education programs and 10 non-standard programs. In addition to graduate medical education, clinical rotations in all the major disciplines are provided for students from the University of Florida College of Medicine in Gainesville.

    Fenway Health organization

    Fenway Health is an LGBT health care, research and advocacy organization founded by Northeastern University students and headquartered in Boston, Massachusetts.

    Anita Rachlis, M.D. is a Canadian HIV/AIDS researcher and is the principal author of the HIV treatment guidelines in Canada. She is an associate scientist at the Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, in Toronto, Ontario, Canada.

    Infectious diseases within American correctional settings are a concern within the public health sector. The corrections population is susceptible to infectious diseases through, exposure to blood and other bodily fluids, drug injection, poor health care, prison overcrowding, demographics, security issues, lack of community support for rehabilitation programs, and high-risk behaviors. The spread of infectious diseases, such as HIV and other sexually transmitted diseases, hepatitis C (HCV), hepatitis B (HBV), and tuberculosis result largely from needle-sharing, drug use, and consensual and nonconsensual sex among prisoners. HIV and hepatitis C need specific attention because of the specific public health concerns and issues they raise.

    The Infectious Diseases Institute (IDI), established within Makerere University, is a Ugandan not-for-profit organization which aims to strengthen health systems in Africa, with a strong emphasis on infectious diseases; through research and capacity development. In pursuit of its mission both in Uganda and Sub-Saharan Africa, IDI provides care to People Living with HIV (PLHIV) and other infectious diseases, builds capacity among healthcare workers through training and ongoing support, maintains a focus on prevention, and carries out relevant research.

    AIDS amendments of 1988 US law

    AIDS amendments of 1988, better known as the Health Omnibus Programs Extension (HOPE) Act of 1988, is a United States statute amending the Public Health Service Act. The Acquired Immune Deficiency Syndrome amendments were compiled as Title II - Programs with Respect to Acquired Immune Deficiency Syndrome within the HOPE Act of 1988. The Title II Act appropriated federal funding for Acquired Immune Deficiency Syndrome (AIDS) education, prevention, research, and testing. The U.S. legislative title provisioned the establishment of the presidentially appointed National Commission on AIDS. The S. 2889 legislation was passed by the 100th U.S. Congressional session and signed by the 40th President of the United States Ronald Reagan on November 4, 1988.

    Cultural competence in healthcare health care services that are respectful of and responsive to the health beliefs, practices and cultural and linguistic needs of diverse patients

    Cultural competence in healthcare refers to the ability for healthcare professionals to demonstrate cultural competence toward patients with diverse values, beliefs, and feelings. This process includes consideration of the individual social, cultural, and psychological needs of patients for effective cross-cultural communication with their health care providers. The goal of cultural competence in health care is to reduce health disparities and to provide optimal care to patients regardless of their race, gender, ethnic background, native languages spoken, and religious or cultural beliefs. Cultural competency training is important in health care fields where human interaction is common, including medicine, nursing, allied health, mental health, social work, pharmacy, oral health, and public health fields.

    Joseph Masci American physician, educator and author

    Joseph Masci is an American physician, educator and author based in Elmhurst, New York City. He is Professor of Medicine and Professor of Preventive Medicine at the Icahn School of Medicine at Mount Sinai. He served as the Director of Department of Medicine at the Elmhurst Hospital Center from 2002 through 2017 when he became Chairman of the Department of Global Health.

    Thomas Charles Merigan is an American virologist and the George E. and Lucy Becker Professor of Medicine, Emeritus at the Stanford University School of Medicine. Merigan's research first focused on viral pathogenesis, basic and clinical studies of interferon, and then developing the first systemic antiviral drugs including those effectively treatIng HIV/AIDS. He is also credited with helping to develop the use of interferons as antiviral and antitumor therapies. Merigan joined the Stanford faculty in 1963 and assumed full emeritus status in 2007. In 2004 he was also identified as one of the 250 most cited investigators in clinical medicine over the last 20 years by the Institute for Scientific Information. He had over 90 postdoctoral fellows, students and visiting scientists with whom he published 576 papers, 24 books and symposia, and held 11 US patents. His students have become leaders in the field of infectious diseases. He was a board member of 28 journals and a member of 23 learned societies. He told his life story in a book entitled Pioneering Viral Therapy,a Life in Academic Medicine, published by Amazon/Kindle/CreateSpace in 2017.

    Adaora Adimora Professor of Medicine and epidemiology

    Adaora Alise Adimora is an American doctor and academic. She is the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centers on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work has highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.